Recent advances in drug discovery of benzothiadiazine and related analogs as HCV NS5B polymerase inhibitors
Authors:
- Debasis DasDDDebasis Das
- Jian HongJHJian Hong
- Shu-Hui ChenSCShu-Hui Chen
- Guangyi WangGWGuangyi Wang
- Leonid BeigelmanLBLeonid Beigelman
- Scott D. SeiwertSSScott D. Seiwert
- Brad O. BuckmanBBBrad O. Buckman
- 1 August 2011
- journal article
- review article
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 19 (16) , 4690-4703
Abstract
No abstract availableKeywords
This publication has 124 references indexed in Scilit:
- Synthesis and biological activity of heteroaryl 3-(1,1-dioxo-2H-(1,2,4)-benzothiadizin-3-yl)-4-hydroxy-2(1H)-quinolinone derivatives as hepatitis C virus NS5B polymerase inhibitorsBioorganic & Medicinal Chemistry Letters, 2009
- HCV NS5B polymerase inhibitors 2: Synthesis and in vitro activity of (1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl) azolo[1,5-a]pyridine and azolo[1,5-a]pyrimidine derivativesBioorganic & Medicinal Chemistry Letters, 2009
- HCV NS5B polymerase inhibitors 3: Synthesis and in vitro activity of 3-(1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl)-4-hydroxy-2H-quinolizin-2-one derivativesBioorganic & Medicinal Chemistry Letters, 2009
- Substituted benzothiadizine inhibitors of Hepatitis C virus polymeraseBioorganic & Medicinal Chemistry Letters, 2009
- HCV NS5B polymerase inhibitors 1: Synthesis and in vitro activity of 2-(1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl)-1-hydroxynaphthalene derivativesBioorganic & Medicinal Chemistry Letters, 2009
- HCV796Hepatology, 2009
- Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 5: Exploration of pyridazinones containing 6-amino-substituentsBioorganic & Medicinal Chemistry Letters, 2008
- Negative‐Strand Hepatitis C Virus (HCV) RNA in Peripheral Blood Mononuclear Cells from Anti‐HCV–Positive/HIV‐Infected WomenThe Journal of Infectious Diseases, 2007
- Predicting sustained virological responses in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD)/ribavirinJournal of Hepatology, 2005
- Recent advances in the molecular biology of hepatitis C virusJournal of Molecular Biology, 2001